Today: 9 June 2026
Browse Category

NASDAQ:PLAB 10 December 2025 - 29 May 2026

Photronics Stock Shock: Earnings Miss Sends Chip-Supply Bet Into a Hard Reset

Photronics Stock Shock: Earnings Miss Sends Chip-Supply Bet Into a Hard Reset

Photronics shares rose 2.23% to $34.78 in premarket trading Friday after plunging 36.4% Thursday on weak quarterly results and a disappointing outlook. The company missed analyst estimates for both adjusted earnings and revenue, and forecast third-quarter sales below Wall Street expectations. Management cited delayed chip-design releases, memory supply constraints, and geopolitical uncertainty.
29 May 2026
··
Photronics Sinks 32% After Q2 Miss

Photronics Sinks 32% After Q2 Miss

Photronics shares plunged 32% Thursday after the company missed quarterly revenue and earnings estimates and cut guidance for the current quarter. Revenue fell to $209.9 million, below forecasts, with IC sales down 5% year over year. The stock last traded at $36.22 on heavy volume. The iShares Semiconductor ETF rose 1.35% in late morning trading.
28 May 2026
···
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 08.01.2026

Royalty Pharma closed at $40.26, up 40% in a year, but a DCF model values shares at $179.83, about 77.6% higher. Camping World Holdings ended at $11.16, with a DCF value of $3.85, suggesting a 190% premium. Photronics traded at $31.78 after a 23.7% monthly gain; DCF analysis estimates intrinsic value at $19.02. Tanger raised $200 million in exchangeable notes and secured $550 million in term loans.
8 January 2026
···
Photronics (PLAB) Stock Soars 45% After Q4 Earnings Beat: AI Photomask Demand Resets the 2026 Outlook

Photronics (PLAB) Stock Soars 45% After Q4 Earnings Beat: AI Photomask Demand Resets the 2026 Outlook

Photronics shares surged 45% to $37.35 on December 11, 2025, after fiscal Q4 results beat expectations and guidance topped forecasts. Q4 revenue reached about $216 million, up 3% sequentially and above analyst estimates. Non-GAAP EPS was $0.60, roughly 33% above consensus. The stock now trades above all major analyst price targets.
11 December 2025
··
Top U.S. Stock Gainers After the Bell on December 10, 2025: ASPC, BBGI, ENVB, PLAB, IRBT, AHT Lead Fed‑Day Rally

Top U.S. Stock Gainers After the Bell on December 10, 2025: ASPC, BBGI, ENVB, PLAB, IRBT, AHT Lead Fed‑Day Rally

The Federal Reserve cut its benchmark rate by 25 basis points Wednesday, marking its third reduction of 2025. The Dow rose 1.05%, the S&P 500 gained 0.67%, and the Nasdaq added 0.33%. Small- and mid-cap stocks saw sharp moves, with Beasley Broadcast Group surging nearly 390%. After-hours trading kept ASPC and ENVB among the top gainers.
10 December 2025
········
Photronics (PLAB) Stock Soars Over 40% on Q4 2025 Earnings Beat and Bullish 2026 Outlook

Photronics (PLAB) Stock Soars Over 40% on Q4 2025 Earnings Beat and Bullish 2026 Outlook

Photronics shares surged over 40% on December 10 after reporting Q4 results that beat expectations, with GAAP net income rising to $61.8 million and diluted EPS doubling to $1.07. Trading volume jumped more than tenfold, and call option activity spiked 1,300%. The stock reached its highest level since the early 2000s, marking its biggest single-day gain since 2008.
10 December 2025
··
Top U.S. Stock Gainers Today (Dec. 10, 2025): ASPC, BBGI, ENVB, PLAB, IRBT & AHT Rocket on Fed Day

Top U.S. Stock Gainers Today (Dec. 10, 2025): ASPC, BBGI, ENVB, PLAB, IRBT & AHT Rocket on Fed Day

A SPAC III Acquisition Corp. surged 267% and Beasley Broadcast Group jumped 224% Wednesday, leading U.S. stock gainers as the S&P 500 stayed flat ahead of a key Federal Reserve decision. Enveric Biosciences rose 79% on patent news. The Fed is expected to cut rates by 25 basis points, with attention on its 2026 rate outlook.
10 December 2025
······

Stock Market Today

  • Plug Power Stock Drops to $3 Amid Cash and Dilution Concerns Ahead of Shareholder Meeting
    June 9, 2026, 9:35 AM EDT. Plug Power (PLUG) shares held near $3.19 before the U.S. open on June 9, down 22% from June 2, as investor concerns about cash liquidity and share dilution re-emerge. The stock slid amid premarket trading while broader markets gained, highlighting investor focus on the company's funding strategy. A Form 144 filing indicated a planned sale of 50,000 shares, adding pressure. Plug Power will webcast its shareholder meeting on June 11, where CEO Jose Luis Crespo will present updates. Recent financials showed a 22% revenue increase to $163.5 million in Q1 but a GAAP net loss of 18 cents per share. The company aims to raise $39.2 million through tax credit sales and plans $275 million from asset monetizations. Concerns remain over dilution as funding needs persist.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Go toTop